INS and Erythema: The findings were that mild erythema measuring 5 × 5 mm developed 15 min after intradermal injection of insulin glulisine, whereas with other insulin formulations redness developed immediately after intradermal injection, and erythema at least 10 mm in diameter and induration at least 5 mm in diameter developed after 15 min (Table 1).